Education
About Us
Working with TipRanks
Follow Us
Galectin Therapeutics Inc (GALT)
NASDAQ:GALT
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ -37.00K | $ -33.00K | $ -32.00K | $ -41.00K | $ -36.00K |
| Operating Income | $ -42.43M | $ -38.07M | $ -38.35M | $ -30.18M | $ -23.44M |
| EBITDA | $ -41.47M | $ -38.24M | $ -37.71M | $ -30.00M | $ -23.34M |
| Net Income | $ -47.05M | $ -41.07M | $ -38.78M | $ -30.53M | $ -23.46M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 15.12M | $ 25.66M | $ 18.59M | $ 39.65M | $ 27.14M |
| Total Assets | $ 17.50M | $ 28.20M | $ 21.29M | $ 41.83M | $ 29.60M |
| Total Debt | $ 106.25M | $ 71.81M | $ 39.87M | $ 29.06M | $ 44.00K |
| Net Debt | $ 91.13M | $ 46.15M | $ 21.28M | $ -10.59M | $ -27.10M |
| Total Liabilities | $ 120.56M | $ 88.44M | $ 53.48M | $ 39.21M | $ 5.41M |
| Stockholders' Equity | $ -103.07M | $ -60.24M | $ -32.19M | $ 2.62M | $ 24.19M |
| Cash Flow | |||||
| Free Cash Flow | $ -41.77M | $ -32.97M | $ -31.06M | $ -24.31M | $ -20.60M |
| Operating Cash Flow | $ -41.77M | $ -32.97M | $ -31.06M | $ -24.31M | $ -20.60M |
| Investing Cash Flow | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Financing Cash Flow | $ 31.23M | $ 40.03M | $ 10.00M | $ 36.81M | $ 263.00K |